Systemic Psoriasis Therapeutics in Asia-Pacific Markets to 2021 - Advent of Novel Biologics and Expanding Treatment Pool to Drive Growth

1
Systemic Psoriasis Therapeutics in Asia-Pacific
Markets to 2021 - Advent of Novel Biologics and
Expanding Treatment Pool to Drive Growth
Single User License - 4995 Site User License
- 9990 Corporate User License -
14985 Publication Date - May 2015 Pages -
94 To know more details, email to
debora_at_reportstack.com
2
Summary

• This report provides insights into psoriasis
  therapeutics in the Asia-Pacific (APAC) market.
  For the purposes of this report, APAC refers to
  the market in China, India, Japan, and Australia
  only. The report estimates the market size for
  2014, along with forecasts until 2021. It also
  covers disease epidemiology, treatment
  algorithms, treatment use patterns, in-depth
  analysis of pipeline molecules, clinical trial
  failure rates, and analysis of recent deals. It
  is built using data and information sourced from
  proprietary databases, primary and secondary
  research, and in-house analysis carried out by a
  team of industry experts. 

3
Scope

• A brief introduction to psoriasis, including
  pathophysiology, etiology, diagnosis, and
  treatment algorithms
• In-depth analysis of currently marketed drugs,
  including analysis of safety, efficacy, treatment
  patterns, and strengths/weaknesses, along with a
  heat map comparing them in terms of safety and
  efficacy
• A comprehensive review of the pipeline for
  psoriasis, including individual analysis of a
  number of late-stage pipeline drugs likely to
  enter the market during the forecast period the
  pipeline is further analyzed on the basis of
  phase distribution, molecule type, program type,
  mechanism of action, and molecular target
• Additional in-depth analysis of pipeline drug
  clinical trials by phase, trial size, trial
  duration, and program failure rate for each
  molecule type

4
Key Benefits

• Understand the psoriasis pipeline and the factors
  that indicate that it is becoming more innovative
• Analyze detailed profiles for promising pipeline
  products and gain insights into how they are
  likely to compete in the market and who their
  main competitors will be
• Follow the trends in psoriasis clinical trial
  size and duration in relation to industry
  averages
• Assess the potential risk of future developmental
  programs for psoriasis therapeutics by mechanism
  of action using recorded clinical trial failure
  rates
• Analyze the potential growth patterns expected
  for the psoriasis market over the forecast period

5
If you are interested...
Contact Debora White Email
debora_at_reportstack.com Ph1-888-789-6604 http/
/www.reportstack.com